Abstract:Introduction The WHO has stated that vaccine hesitancy is a serious threat to overcoming COVID-19. Vaccine hesitancy among underserved and at-risk communities is an ongoing challenge in Canada. Public confidence in vaccine safety and effectiveness and the principles of equity need to be considered in vaccine distribution. In Canada, governments of each province or territory manage their own healthcare system, providing an opportunity to compare and contrast distribution strategies. The overarching objective of this study is to identify effective vaccine distribution approaches and advance knowledge on how to design and implement various strategies to meet the different needs of underserved communities. Methods and analysis Multiple case studies in seven Canadian provinces will be conducted using a mixed-methods design. The study will be informed by Experience-Based CoDesign techniques and theoretically guided by the Socio-Ecological Model and the Vaccine Hesitancy Matrix frameworks. Phase 1 will involve a policy document review to systematically explore the vaccine distribution strategy over time in each jurisdiction. This will inform the second phase, which will involve (2a) semistructured, in-depth interviews with policymakers, public health officials, researchers, providers, groups representing patients, researchers and stakeholders and (2b) an analysis of population-based administrative health data of vaccine administration. Integration of qualitative and quantitative data will inform the identification of effective vaccine distribution approaches for various populations. Informed by this evidence, phase 3 of the study will involve conducting focus groups with multiple stakeholders to codesign recommendations for the design and implementation of effective vaccine delivery strategies for equity-deserving and at-risk populations. Ethics and dissemination This study is approved by the University of Toronto's Health Sciences Research Ethics Board (#42643), University of British Columbia Behavioural Research Ethics Board (#H22-01750-A002), Research Ethics Board of the Nova Scotia Health Authority (#48272), Newfoundland and Labrador Health Research Ethics Board (#2022.126), Conjoint Health Research Ethics Board, University of Calgary (REB22-0207), and University of Manitoba Health Research Board (H2022-239). The outcome of this study will be to produce a series of recommendations for implementing future vaccine distribution approaches from the perspective of various stakeholders, including equity-deserving and at-risk populations.

Challenges of Equitable Vaccine Distribution in the COVID-19 Pandemic

Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution

Barriers and Facilitators to Vaccine Equity Amidst the COVID-19 Vaccine Rollout in the United States

Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future

COVID-19 Vaccine Challenges in Developing and Developed Countries

Vaccination Worldwide: Strategies, Distribution and Challenges

COVID-19 Vaccination and Public Health: Addressing Global, Regional, and Within-Country Inequalities

Using absolute risk reduction to guide the equitable distribution of COVID-19 vaccines

What are effective vaccine distribution approaches for equity-deserving and high-risk populations during COVID-19? Exploring best practices and recommendations in Canada: protocol for a mixed-methods multiple case codesign study

Factors, enablers and challenges for COVID-19 vaccine development

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Mobile Apps Prioritizing Privacy, Efficiency and Equity: A Decentralized Approach to COVID-19 Vaccination Coordination

The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States

An Equity-Focused Comprehensive Analysis of COVID-19 Vaccine Rollout and Prioritization Strategies Across Six Canadian Provinces: Addressing the Needs of Vulnerable and High-Risk Populations

An ethical framework for global vaccine allocation

COVID-19: vaccination, therapeutics and a review of the science and public health

Global COVID-19 vaccine inequity: The scope, the impact, and the challenges

Reimagining Vaccine Access for Health Equity

The mobile vaccine equity enhancement program-a model program for enhancing equity in vaccine availability based at a large health care system

Efforts at COVID-19 Vaccine Development: Challenges and Successes

Prioritizing ‘equity’ in COVID-19 vaccine distribution through Global Health Diplomacy